Insmed Inc (INSM)

Insmed Inc (INSM) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $20.4B; returns 1 day -1.8%, 1 week -3.0%, 1 year -41.7%.

Insmed Incorporated is a global biopharmaceutical company focused on developing and commercializing therapies for patients with rare and serious diseases, particularly difficult-to-treat pulmonary infections. The company's portfolio is shifting from a single-product focus to a dual-commercial product strategy.

Groups INSM belongs to

• Healthcare
• Biopharmaceutical
• Rare Diseases
• Biotechnology
• Commercial Stage Biotech
• Bronchiectasis Treatment
• Infectious Diseases
• Life Sciences
• Clinical Stage
• Pharmaceuticals
• Unmet Medical Needs

INSM financial model: income statement, cash flow and balance sheet